DES risk questions linger for years in DES exposed families
Dr. William Goldway discusses the DES drug linked to rare vaginal cancer in daughters born to mothers who took it in pregnancy. He notes exposed girls show adenosis and potential cancer risk, while some sons show reduced sperm counts but no cancer cases yet. Regular gynecologic exams and careful communication are advised.